Celsion's Phase III Blockbuster Data Revealed And It's Been Right Underneath Your Nose
Disclosure: I am long CLSN. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
"...one of the most important new drugs in a generation"
"...perhaps a blockbuster by anybody's definition"
-- Celsion (CLSN) CEO Michael H. Tardugno in a recent presentation.
There's been a lot of scientific and medical debate from bulls and bears as to why the Celsion ThermoDox drug in Phase III results should work or not. Forget "should" -- there's already enough data publicly revealed to prove mathematically that ThermoDox already has worked. I'll explain.
There have been many great articles already recently that dive into the scientific and medical background about this study. I will direct you to my personal two favorite articles (here and here) which I agree with its contents and leave it at that. This article's intent is to move on from theory and analyze what is already a historically revealed fact. READ FULL ARTICLE HERE